GlassScriptPhysician profile
Gregory J Austin
NPI 1285620138
$569.49
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $174 · 2021: $131 · 2022: $45.79 · 2023: $23.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $239.41 | 2019-2021 | |
| Amgen INC. | $56.10 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $50.08 | 2020-2023 | Xiaflex |
| Zyla Life Sciences, INC. | $42.58 | 2019 | |
| Integra Lifesciences Corporation | $38.87 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.99 | 2019 | |
| Bioventus LLC | $29.64 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $19.75 | 2020 | |
| Ferring Pharmaceuticals INC. | $17.95 | 2022 | |
| Baudax Bio INC. | $16.19 | 2020 | |
| Avanos Medical | $13.17 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.